| P2093 | author name string | Maurizio Benucci | |
| | Francesca Bandinelli | |
| | Valentina Grossi | |
| | Maria Infantino | |
| | Mariangela Manfredi | |
| | Arianna Damiani | |
| | Francesca Li Gobbi | |
| P2860 | cites work | High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 |
| | Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients | Q79808209 |
| | Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 |
| | The impact of abatacept treatment on the vasculature in patients with rheumatoid arthritis | Q85488080 |
| | Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis | Q26749294 |
| | Association Between Interleukin-6 -572 C>G and -174 G>C Polymorphisms and Hypertension: A Meta-analysis of Case-control Studies | Q26772066 |
| | Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients. | Q33730073 |
| | High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study | Q34090034 |
| | The immune system in atherosclerosis | Q34164644 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? | Q34601733 |
| | Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 |
| | Patterns of cardiovascular risk in rheumatoid arthritis | Q35638493 |
| | T-cell costimulation and coinhibition in atherosclerosis. | Q37143018 |
| | Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis. | Q37372691 |
| | Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies | Q38181283 |
| | Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study | Q38937245 |
| | Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment | Q39051253 |
| | The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis | Q40053146 |
| | Association between interleukin-6/6R gene polymorphisms and coronary artery disease in Russian population: influence of interleukin-6/6R gene polymorphisms on inflammatory markers. | Q42373187 |
| | Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial | Q42611547 |
| | Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis | Q43049221 |
| | Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. | Q46802505 |
| | Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody | Q47368581 |
| | Aldehyde dehydrogenase 2 (ALDH2) polymorphism gene and coronary artery disease risk: a meta-analysis. | Q51554625 |
| | Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages. | Q53159690 |
| | T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development | Q56897334 |
| | Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort | Q57804967 |
| | A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis | Q60593768 |
| | Endothelial Function | Q61704068 |
| | HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis | Q61971712 |
| | Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects | Q73628316 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 247-252 | |
| P577 | publication date | 2018-06-07 | |
| P1433 | published in | Journal of Inflammation Research | Q6295349 |
| P1476 | title | Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis | |
| P478 | volume | 11 | |